ZYX MULTI-ASSET GLOBAL ALLOCATION MODEL Q1 2010 PERFORMANCE REVIEW

The model gives precedence to risk control over potential rewards. The model is designed to maximize risk adjusted returns over…
Read more »
 

NEW UPDATE ON MULTI-ASSET GLOBAL ALLOCATION MODEL

For new update on Multi-Asset Global Allocation Model, please visitAllocation THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE…
Read more »

You are receiving less than 2% of the content from our paid services ...TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE 30 day trial.

Check out our enviable performance in both bull and bear markets.

 

PER THE PRIOR POST SHORT ON $VECO FROM $44.20

THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND…
Read more »
 

COMPETITION MAY BE COMING TO $VECO (VEECO INSTRUMENTS)

VECO has lately been a favorite of the momentum players. Fundamental have justified the momentum as the company's solutions for…
Read more »

You are receiving less than 2% of the content from our paid services ...TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE 30 day trial.

Check out our enviable performance in both bull and bear markets.

 

CHANGE IN THE LONG SHORT EQUITIES ALLOCATION MODEL

With S&P500 June futures at 1176, there is change in our Long Short Equities Model. Please visit Allocation Model page…
Read more »
 

THE RESERVE BANK OF INDIA RAISES INTEREST RATES

Our Global Multi-Asset Allocation Model has a long allocation to India. The Reserve Bank of India raised its short-term lending…
Read more »
 

TAKE PARTIAL PROFITS ON $STJ (ST. JUDE MEDICAL) RIGHT HERE AT $39.02. TIGHT STOP ON THE REST.

THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND…
Read more »
 

FDA APPROVES EXPANDED USE OF $BSX (BOSTON SCIENTIFIC) DEVICES

Typically we refrain from posting on this blog the information that is easily available elsewhere. In view of us taking…
Read more »
 

NOBLE ON $BSX

Noble Financial's checks at Boston Scientific indicate ICD's and CRT-Ds could return back to the market in 5 days versus…
Read more »
 

12.5% GAIN ON $BSX (BOSTON SCIENTIFIC) IN THE FACE OF SEVERAL BROKER DOWNGRADES

In spite of a negative article in Barron's Online and two new broker downgrades, we have gain at $ This…
Read more »
Follow

Get every new post delivered to your Inbox

Join other followers

make money

316 WINNING TRADES

20 LOSING TRADES

1122.66% ANNUALIZED AVERAGE RETURN PER TRADE

..........CHECK OUT FREE TRIALS

START GENERATING WEALTH NOW!